Peginterferon-Alfa2a Plus Ribavirin for 48 Versus 72 Weeks in Patients With Detectable Hepatitis C Virus RNA at Week 4 of Treatment-Reference-Cited by-同舟云学术

Peginterferon-Alfa2a Plus Ribavirin for 48 Versus 72 Weeks in Patients With Detectable Hepatitis C Virus RNA at Week 4 of Treatment

Published:2006-08 Issue:2 Volume:131 Page:451-460
ISSN:0016-5085
Container-title:Gastroenterology
language:en
Short-container-title:Gastroenterology

Author:

Sánchez–Tapias José M.,Diago Moisés,Escartín Pedro,Enríquez Jaime,Romero–Gómez Manuel,Bárcena Rafael,Crespo Javier,Andrade Raúl,Martínez–Bauer Eva,Pérez Ramón,Testillano Milagros,Planas Ramón,Solá Ricard,García–Bengoechea Manuel,Garcia–Samaniego Javier,Muñoz–Sánchez Miguel,Moreno–Otero Ricardo

Publisher

Elsevier BV

Subject

Gastroenterology,Hepatology

Reference25 articles.

1. Peginterferon alfa-2b plus ribavirin compared with interferon alfa-2b plus ribavirin for the initial treatment of chronic hepatitis C;Manns;Lancet,2001

2. Peginterferon alfa-2a plus ribavirin for chronic hepatitis C virus infection;Fried;N Engl J Med,2002

3. Peginterferon-alpha2a and ribavirin combination therapy in chronic hepatitis C;Hadziyannis;Ann Intern Med,2004

4. National Institutes of Health Consensus Development Conference Statement: management of hepatitis C: 2002;Hepatology,2002

5. Management of hepatitis C;Alberti;J Hepatol,2003

Cited by 306 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Hepatitis C virus treatment failure: Clinical utility for testing resistance-associated substitutions;World Journal of Hepatology;2021-09-27

2. The Evolution of Clinical Trials for Hepatitis C;Topics in Medicinal Chemistry;2019

3. Metabolic Manifestations of Hepatitis C Virus;Clinics in Liver Disease;2017-08

4. Evaluation of Temporal Virological Responses to Interferon-α-2b plus Ribavirin among Genotype 3a Hepatitis C Virus-Infected Patients;Intervirology;2017

5. A Review of Hepatitis C in the General Population in Pakistan;Viral Hepatit Dergisi;2016-12-15